{
  "ptid_time": "014_S_4079_2011-12-15",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4079/2011-12-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 21,417 mm³, 4.1% below the reference mean. With a Z-score of -0.10 (45.9th percentile), this represents normal volume ; hippocampal volume measures 5,710 mm³, 25.7% below the reference mean. With a Z-score of -2.88 (0.2th percentile), this represents significant atrophy; whole brain volume measures 1,019,380 mm³, 1.0% below the reference mean. With a Z-score of -0.12 (45.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,799 mm³, 28.1% below the reference mean. With a Z-score of -2.18 (1.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,893 mm³, 23.7% below the reference mean. With a Z-score of -2.67 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 16,259 mm³, 20.8% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 65.0 years. Gender is Female. Education: 20 years. MMSE: 25.0. MoCA: 23.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and moderate atrophy in the middle temporal gyrus—all regions strongly implicated in Alzheimer's disease. The cognitive scores (MMSE 25, MoCA 23) are borderline but suggest mild impairment, consistent with early neurodegeneration. The presence of one APOE4 allele further increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology).  \n\n**Confidence:** **High** (due to clear structural atrophy in AD-vulnerable regions and borderline cognitive scores).  \n\n*Note: Progression to dementia is likely if atrophy and cognitive decline continue at this rate. Follow-up clinical and biomarker assessments (e.g., CSF Aβ/tau or PET) would strengthen the diagnosis.*",
  "timestamp": "2025-07-25T23:51:25.880443"
}